Improving treatments for alcohol use disorders and related liver disease
Translational Alcohol Research Program (TARP)
['FUNDING_TRAINING'] · YALE UNIVERSITY · NIH-10836451
This study is helping new researchers learn how to use the latest science and technology to find better ways to treat people struggling with alcohol use problems and liver disease related to alcohol.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | YALE UNIVERSITY (nih funded) |
| Locations | 1 site (NEW HAVEN, UNITED STATES) |
| Trial ID | NIH-10836451 on ClinicalTrials.gov |
What this research studies
The Translational Alcohol Research Program (TARP) aims to train emerging post-doctoral researchers to effectively apply knowledge from basic science to clinical and social behavioral research focused on alcohol use disorders (AUD) and alcohol-related liver disease (ALD). This program emphasizes the importance of integrating new research tools, such as genomic and imaging technologies, to enhance the understanding and treatment of these conditions. By bridging the gap between basic and clinical sciences, TARP seeks to accelerate the development of innovative treatments for individuals affected by AUD and ALD.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals struggling with alcohol use disorders or those diagnosed with alcohol-related liver disease.
Not a fit: Patients who do not have alcohol use disorders or related liver diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and better management strategies for patients suffering from alcohol use disorders and related liver diseases.
How similar studies have performed: Previous research has shown promise in bridging basic and clinical sciences in the treatment of alcohol-related conditions, indicating that this approach could yield significant advancements.
Where this research is happening
NEW HAVEN, UNITED STATES
- YALE UNIVERSITY — NEW HAVEN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VASILIOU, VASILIS — YALE UNIVERSITY
- Study coordinator: VASILIOU, VASILIS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.